---
figid: PMC7235714__diagnostics-10-00216-g001
figlink: pmc/articles/PMC7235714/figure/diagnostics-10-00216-f001/
number: F1
caption: Mechanism of action of immune checkpoint inhibitors (ICIs). The binding together
  of MHC-peptide (peptide = tumor antigen) and TCR activates the anti-cancer pathway
  of T-cell–mediated immune response. The binding of CTLA-4 to its ligand and PD-1
  to PD-L1, on the contrary, inhibit the anti-cancer pathway. The binding of monoclonal
  antibodies, such as ICIs, to CTLA-4, PD-1 or PD-L1 prevent the deactivation of the
  anti-cancer pathway.
pmcid: PMC7235714
papertitle: Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy.
reftext: Vanina Vani, et al. Diagnostics (Basel). 2020 Apr;10(4):216.
pmc_ranked_result_index: '30500'
pathway_score: 0.6506124
filename: diagnostics-10-00216-g001.jpg
figtitle: Action of immune checkpoint inhibitors (ICIs)
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7235714__diagnostics-10-00216-g001.html
  '@type': Dataset
  description: Mechanism of action of immune checkpoint inhibitors (ICIs). The binding
    together of MHC-peptide (peptide = tumor antigen) and TCR activates the anti-cancer
    pathway of T-cell–mediated immune response. The binding of CTLA-4 to its ligand
    and PD-1 to PD-L1, on the contrary, inhibit the anti-cancer pathway. The binding
    of monoclonal antibodies, such as ICIs, to CTLA-4, PD-1 or PD-L1 prevent the deactivation
    of the anti-cancer pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRA
  - TRB
  - TRD
  - TRG
  - APC
  - CTLA4
  - PDCD1
  - cancer
genes:
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: АРС
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: 'APC:'
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: 'TCR:'
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: 'TCR:'
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: 'TCR:'
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: 'TCR:'
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
chemicals: []
diseases:
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7235714__F1
redirect_from: /figures/PMC7235714__F1
figtype: Figure
---
